GE Healthcare files patent lawsuit against Bio-Rad
05-12-2018
General Electric (GE) has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
general electric, thermo fisher scientific, GE healthcare, cell culture, gene modulation, magnetic beads
